Hatch Takes Aim At Kennedy’s Commissioner Criteria, Supports Crawford

Ties to an FDA-regulated industry should not preclude a candidate's nomination to the agency's top position, Sen. Orrin Hatch (R-Utah) asserted April 16 at the Food & Drug Law Institute Educational Conference in Washington, D.C

More from Archive

More from Medtech Insight